Sponsor pipeline

Abcuro, Inc. clinical trial pipeline

Get alerts when Abcuro, Inc.'s trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 1 with a notable change, 0 with minor changes only.

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Active trials by phase

Phase 2/3
1

Active trials

NCT IDTitleConditionStatusUpdated
Phase 2/3
NCT06450886 Long-term Extension Study of Ulviprubart (ABC008) in Subjects With Inclusion Body Myositis Inclusion Body Myositis (IBM) Active, Not Recruiting 2025-07-28
Get alerts when Abcuro, Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free